Patents by Inventor Ilias Alevizos

Ilias Alevizos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240084024
    Abstract: A human CD40L-specific Tn3 molecule and therapeutic uses thereof for the treatment of lupus nephritis are provided herein. Also provided are therapeutic regimens that comprise a CD40L-specific Tn3 scaffold.
    Type: Application
    Filed: November 15, 2023
    Publication date: March 14, 2024
    Inventors: Gabor G. ILLEI, Ilias ALEVIZOS, Jorn DRAPPA, William A. REES
  • Publication number: 20200345991
    Abstract: This disclosure generally relates to devices, systems, or kits of color-coded dilation probes and corresponding sheath or jacket catheters that dilate tissue in an atraumatic manner to a desired depth and diameter for the insertion of a cannula. A jacketed catheter may be engaged to the probes and inserted into the dilated tissue to form a fluid-tight seal. An infusate is then introduced into the tissue through the catheter and held in the tissue for a desired period of time.
    Type: Application
    Filed: October 26, 2018
    Publication date: November 5, 2020
    Inventors: John A. Chiorini, Blake M. Warner, Ilias Alevizos
  • Patent number: 8785414
    Abstract: The identification of differentially expressed microRNAs in patients with Sjögren's syndrome is disclosed herein. Provided is a method of diagnosing a subject as having Sjögren's syndrome by measuring the level of at least one differentially expressed miR gene product identified herein. An alteration in the level of the at least one miR gene product in the biological sample of the subject relative to a control indicates the subject has Sjögren's syndrome. Also provided is a method of treating a patient with Sjögren's syndrome by administering to the patient a therapeutically effective amount of an agent that inhibits expression of a miR gene product that is up-regulated in the patient with Sjögren's syndrome relative to a control, or by administering to the patient a therapeutically effective amount of an isolated miR gene product that is down-regulated in the patient with Sjögren's syndrome relative to a control. A method of restoring salivary flow in a patient with Sjögren's syndrome is also provided.
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: July 22, 2014
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Ilias Alevizos, Gabor Illei
  • Publication number: 20120029056
    Abstract: The identification of differentially expressed microRNAs in patients with Sjögren's syndrome is disclosed herein. Provided is a method of diagnosing a subject as having Sjögren's syndrome by measuring the level of at least one differentially expressed miR gene product identified herein. An alteration in the level of the at least one miR gene product in the biological sample of the subject relative to a control indicates the subject has Sjögren's syndrome. Also provided is a method of treating a patient with Sjögren's syndrome by administering to the patient a therapeutically effective amount of an agent that inhibits expression of a miR gene product that is up-regulated in the patient with Sjögren's syndrome relative to a control, or by administering to the patient a therapeutically effective amount of an isolated miR gene product that is down-regulated in the patient with Sjögren's syndrome relative to a control. A method of restoring salivary flow in a patient with Sjögren's syndrome is also provided.
    Type: Application
    Filed: March 31, 2010
    Publication date: February 2, 2012
    Inventors: Ilias Alevizos, Gabor Illei
  • Publication number: 20040181344
    Abstract: Disclosed are diagnostic methods for oral diseases such as oral cancer. In the methods, expression data of a plurality of genes associated with an oral disease is examined and compared to signature expression profile indicative of an oral disease. Also disclosed are systems, methods and kits for allowing a dentist to provide for detection of oral disease at the point of patient care.
    Type: Application
    Filed: November 18, 2003
    Publication date: September 16, 2004
    Applicant: Massachusetts Institute of Technology
    Inventors: Gregory Stephanopoulos, Ilias Alevizos, Jatin Misra
  • Publication number: 20020169562
    Abstract: Disclosed are a variety of methods and computer systems for use in the analysis of gene and protein expression data. Also disclosed are methods for the definition of the cellular state of cells and tissues from multidimensional physiological data such as those obtained from gene expression measurements with DNA microarrays. A variety of classification methods can be applied to expression data to achieve this goal. Demonstrated is the application of several statistical tools including Wilks' lambda ratio of within-group to total variance, Fisher Discriminant Analysis, and the misclassification error rate to the identification of discriminating genes and the overall classification of expression data. Examples from several different cases demonstrate the ability of the method to produce well-separated groups in the projection space representing distinct physiological states. The method can be augmented and is useful in disease diagnosis, drug screening and bioprocessing applications.
    Type: Application
    Filed: January 29, 2002
    Publication date: November 14, 2002
    Inventors: Gregory Stephanopoulos, Jatin Misra, Daehee Hwang, William A. Schmitt, Ilias Alevizos, Saliya Sudharshana Silva, Ryan T. Gill